Gladstone Molecular Neurobiology Program transgenic mice was invariably fatal within 19 days in and Department of Neurology the absence of CNS pathology. We examined vital peUniversity of California ripheral organs for expression of transgene-derived San Francisco, California 94141-9100 HSV-TK and for pathological changes. RT-PCR screening of transgenic mice revealed expression of Gfap and HSV-Tk in gut, heart, lung, liver, kidney, adrenal, and Summary spleen. Histopathological examination of these organs in transgenic animals receiving GCV revealed major To investigate the roles of astroglial cells, we targeted changes only in the gastrointestinal (GI) tract, which their ablation genetically. Transgenic mice were genshowed severe inflammation and necrosis of the jejuerated expressing herpes simplex virus thymidine kinum and ileum. Our investigations show that this patholnase from the mouse glial fibrillary acidic protein ogy is related to the ablation of GFAP-expressing enteric (GFAP) promoter. In adult transgenic mice, 2 weeks glia. of subcutaneous treatment with the antiviral agent ganciclovir preferentially ablated transgene-expressResults ing, GFAP-positive glia from the jejunum and ileum, causing a fulminating and fatal jejuno-ileitis. This pa-
Generation of HSV-TK Expressing Transgenic Mice thology was independent of bacterial overgrowth and
Progeny resulting from the pronuclear injection of a was characterized by increased myeloperoxidase acGfap-HSV-Tk fusion gene construct were screened for tivity, moderate degeneration of myenteric neurons, successful integration of the transgene (Figures 1A and and intraluminal hemorrhage. These findings demon-1B). Transgenic lines were established from three founder strate that enteric glia play an essential role in mainmice. Of these, line 7.1 showed the highest expression taining the integrity of the bowel and suggest that of HSV-TK protein in the brain. Densitometry of Southern their loss or dysfunction may contribute to the cellular blots estimated the number of copies of transgene incormechanisms of inflammatory bowel disease.
porated into the genome of transgenic progeny of line 7.1 to be over 50. Males of line 7.1 were infertile in agreement with previous reports of male sterility in Introduction transgenic mice expressing HSV-TK from other promoters (Al-Shawi et al., 1988) . All experimental animals were Astroglia are among the most numerous cells in all neugenerated by mating heterozygous females of line 7.1 ral systems. Many aspects of their functions are not well with wild-type males, followed by genotyping by Southunderstood. To investigate the roles of astrocytes and ern blot and immunohistochemical demonstration of related astroglia in the central (CNS) and peripheral ner-HSV-TK expression. Thus, transgenic and nontransgenic vous systems, we targeted their cell death genetically control animals had similar genetic backgrounds. using the promoter of glial fibrillary acidic protein (GFAP), Production of HSV-TK protein by transgenic mice was an intermediate filament protein (Eddleston and Mucke, demonstrated by Western blot of whole brain extracts 1993). Mouse Gfap promoter sequences have been ( Figure 1C ) and immunohistochemistry. HSV-TK was present only in cells with the appearance of astrocytes 6 To whom correspondence should be addressed.
( Figures 1D and 1E ). In double-labeling studies, HSV- TK was always colocalized with GFAP in uninjured mice double-staining for GFAP (blue) plus HSV-TK (brown) (F and H) in the (F and G) Two-color staining of HSV-TK (brown) and GFAP (blue) forebrain of GCV-treated mice 14 days after stab injury (arrowheads). shows that brown-stained cell bodies and blue-stained processes Scale bar for (E) and (G) ϭ 35 m; for (F) ϭ 12 m. (E and F) belong to the same cells.
Nontransgenic. GCV had no effect on astrocyte scar formation. (G and H) Transgenic. GCV has depleted astrocytes from the wound margins. Neighboring astrocytes have upregulated GFAP and appear swollen and fragmented (arrows in [H] ).
or after stab injury to the forebrain, which increased the number, size, and staining intensity of reactive astrocytes ( Figures 1F and 1G ). HSV-TK was undetectable in at least 7 days caused a mean cell loss of 75% in cultures nontransgenic littermates.
from transgenic mice but not their nontransgenic littermates (Figures 2A and 2B ). Immunohistochemistry GCV Mediated Killing of GFAP-HSV-TK Transgenic confirmed the specific loss of GFAP-positive cells and Astrocytes In Vitro and after Brain showed a relative increase in GFAP-negative cells in Injury In Vivo GCV-treated transgenic cultures ( Figures 2C and 2D ). The vulnerability of transgenic astrocytes to GCV was These findings show that astrocytes from transgenic tested in vitro using enriched, subconfluent astrocyte mice, but not their nontransgenic littermates, were killed cultures from individual neonatal mice, in which about 80% of cells were GFAP-positive. Exposure to GCV for by GCV in vitro, and that diffusion of toxic metabolites of GCV produced by transgenic cells was not lethal to neighboring GFAP-negative cells. The ability of s.c. GCV to kill astrocytes in vivo was tested after stab injury to the brain, a procedure known to upregulate GFAP expression and cause astrocyte proliferation (Eddleston and Mucke, 1993) . Because in vitro experiments indicated that prolonged exposure to GCV was needed to achieve substantial ablation of transgenic astrocytes, GCV was delivered continuously in vivo by s.c. osmotic minipump. The astrocytic reaction and glial scar induced by stab injury to the forebrain were robust in GCV-treated nontransgenic mice or untreated transgenic or nontransgenic mice (n ϭ 3-6 mice per group) ( Figures 2E and 2F ). In contrast, transgenic mice treated with GCV for 7 or 14 days (n ϭ 6 per group) exhibited markedly fewer GFAP and HSV-TK immunoreactive astrocytes adjacent to the wound (Figures 2G and 2H) . The pattern of immunohistochemical staining at 7 and 14 days suggested that the GCV-induced death of astrocytes next to the wound margin triggered an astrocytic reaction in adjacent tissue, where many astrocytes looked fragmented, abnormal, and in an early stage of cell death (Figures 2G and 2H) .
Fatality of Chronic s.c. GCV Delivery to Transgenic Mice
When continuous s.c. GCV treatment was attempted for longer times, transgenic mice became ill and died within Transgenic mice treated with GCV for 7 days and discontinued (n ϭ 6) survived for 35 days after the start of GCV (the longest time monitored) and looked healthy.
as well as in neural tissues such as brain and trigeminal ganglion ( Figure 4A ). No gross or histopathological abTransgenic mice treated with GCV for 14 days and discontinued (n ϭ 6) became terminally ill by day 18 after normalities were detected in any major organ in untreated transgenic mice (n ϭ 4 per group) or in nonthe start of GCV, indicating that the lethal changes induced in these mice became irreversible between days transgenic mice given GCV for 14 days. Transgenic mice given GCV for 14 days (n ϭ 8) also showed no obvious 7 and 14. In contrast, s.c. GCV administered continuously for 28 days (the longest time studied) had no destructural changes to lung, heart, pancreas, kidney, liver, adrenal, spleen, stomach, or colon. However, these tectable effects on nontransgenic animals (n ϭ 6) (Figures 3A and 3B) .
mice exhibited pronounced macroscopic changes of the small intestine in all cases ( Figures 4C-4H ), which To look for potential causes of death, we examined the CNS in detail, in particular vital centers in the hypocorrelated with a depletion of Gfap and HSV-Tk mRNA from the small intestine but not other vital organs (Figthalamus and brainstem. Uninjured transgenic mice that received s.c. GCV for 14-17 days (n ϭ 9) showed little ures 4A and 4B). The GI tract was therefore studied in greater detail. or no increase in GFAP-immunoreactivity and no evidence of astrocyte loss or neuronal damage throughout the CNS, compared with similarly processed control Pronounced Inflammation and Necrosis of the Jejunum and Ileum, Severe Blood Loss, mice ( Figures 3C-3J ).
In the absence of an obvious cause of death due to and Positive Blood Cultures in GCV-Treated Transgenic Mice CNS dysfunction, we looked for other sites that might account for lethality. RT-PCR screening revealed exMacroscopic and microscopic examination of the GI tract in untreated transgenic mice (n ϭ 6) or in nonpression of Gfap and HSV-Tk in major organs including heart, lung, liver, spleen, adrenal, kidney, and GI tract, transgenic mice receiving GCV for 11 or 14 days (n ϭ 6) revealed no evidence of abnormalities (Figures 4C  and 4G; 5A , 5B, 5D, and 5E). In transgenic mice given GCV for 7 days (n ϭ 6), the GI tract exhibited small patches of focal inflammation, but there were no quantitative histopathological changes ( Figure 5A ), and there was no occult blood in the stool. In transgenic mice given GCV for 11 or more days (n ϭ 18), the fecal contents were black, melanic ( Figures 4D, 4F , and 4H-4J), and tested positively for occult blood. Macroscopically, the jejunum and ileum exhibited severe inflammation and hemorrhage, and moderate distension; the duodenum was not affected severely, and the esophagus, stomach, and colon appeared normal ( Figures 4D, 4E , 4F, and 4H-4K). There was never any evidence of stasis of gut contents, and in all cases there were normally formed stool pellets in the colon ( Figures 4D, 4F , and 4J). Changes in the small bowel were patchy, appearing as skip lesions, which varied in severity from small inflammatory foci interspersed amongst normal tissue to large aphthoid and linear ulcers exhibiting gangrenous necrosis in extreme cases (Figures 4K and 4L) . There was regular evidence of adhesions. The ileum was generally more severely affected than the jejunum, but within the ileum, lesions occurred with equal frequency within the proximal, central, or distal portions. The mucosal surface exhibited many areas of superficial erosion covered with inflammatory exudate and cellular debris. Microscopic analysis of the jejunum and ileum revealed a perturbed crypt-villus architecture and mucosal hyperplasia with a statistically significant 50% increase in crypt depth (Figures 5A-5G). Villus atrophy was not pronounced ( Figure 5A ), but villi exhibited cellular abnormalities ranging from mild epithelial changes and nonspecific granulocytic infiltrate of neutrophils and other leukocytes (Figures 5F) to marked hemorrhagic necrosis ( Figure 5G ). Microscopy confirmed the patchy nature of the pathology, with abnormal regions immediately adjacent to more normally appearing areas (Figures 5C) . Pathology appeared to initiate in the villus tips with flattening, vacuolization, and loss of polarity of the surface epithelium, loss of the brush border and goblet cells, interstitial edema separating the epithelium from the lamina propria, and pronounced dilation of capillaries with erythrostasis ( Figures 5D, 5F , and 5G; 8D, 8E, and 8G). These changes were observed frequently in the absence of hemorrhage or necrosis, whereas the reverse was not encountered. Progression of these changes included increased sloughing of epithelial cells and 6F ). Cross sections showed widespread loss of GFAP-positive glial cells and their processes ever, the smooth muscle wall exhibited a qualitatively obvious and statistically significant 100% thickening from the submucosal regions and the lamina propria of villi throughout the jejunum and ileum ( Figures 6I and  (Figures 5A-5C ). Other regions of the GI tract, in particular the colon, appeared microscopically normal by quali-6J). All regions with histopathological abnormalities exhibited severe loss of glia ( Figure 6J ). In contrast, the tative and quantitative analysis (Figures 5I-5K ).
Blood cell counts and serum chemistry were normal in colon of GCV-treated transgenic mice exhibited either a small, or no obvious, loss of immunoreactive enteric untreated transgenic mice, in nontransgenic mice given GCV for 14 days, and in transgenic mice given GCV for glia ( Figures 6K and 6L ). These findings indicate that GCV treatment caused a highly selective, severe abla-7 days. Transgenic mice with mild signs of illness after 14 days of GCV had red blood cell counts and hemoglobin tion of enteric glial cells from the jejunum and ileum of transgenic mice, which correlated spatially and tempolevels reduced to about 60% of normal, with up to 10-fold elevations of nucleated red blood cells, up to 20-rally with the severe inflammation and hemorrhagic necrosis also induced by this treatment. fold elevations of neutrophils, and mild (about 30%) elevations of serum urea. Moribund GCV-treated transgenic mice exhibited severe anemia with red blood cell counts Changes of Enteric Neurons in the Jejunum and Ileum of GCV-Treated Transgenic Mice and hemoglobin levels reduced to less than 25% of normal, accompanied by high levels of nucleated red
In the CNS, GFAP-positive astrocytes provide supportive and protective roles for nerve cells (Eddleston and cells and neutrophils relative to the number of red blood cells, and markedly elevated (Ͼ3-fold) serum urea. Mean Mucke, 1993). We therefore looked for effects that ablation of enteric glia might have on enteric neurons. Wholecorpuscular volume and hemoglobin, and the number of thrombocytes were in the normal range in all animals. mount preparations of jejunum and ileum were doublelabeled for GFAP and cuprolinic blue, a specific marker These findings ruled out bone marrow failure. Serum creatinine and other serum chemistry values were also for enteric neurons (Holst and Powley, 1995; . In control mice (n ϭ 6), myenteric normal. High levels of serum urea combined with normal serum creatinine indicate normal kidney function comneurons were completely enveloped by a dense network of glial cell processes ( Figure 7C ). In transgenic mice bined with GI bleeding. Bacterial cultures prepared from blood, peritoneal fluid, and spleen showed no growth treated with GCV for 11 days or more (n ϭ 7), this network was markedly depleted, with a patchy variation in severof gram-negative organisms in control mice whereas transgenic animals treated with GCV for 14 days showed ity. In areas where some glial cells remained, the neurons appeared more or less normal and were denuded of Ͼ300 colonies per spleen or ml of blood or peritoneal fluid. Together, these findings were compatible with seenveloping glial processes to varying degrees ( Figure  7D ). Where glial cells and processes were largely absent, vere hemorrhage into the intestinal tract and perforation of the intestine accompanied by bacteremia as causes there was evidence of neuronal atrophy and loss ( Figure  7E ). To investigate neuronal changes quantitatively, we of acute decline and death in transgenic mice treated with GCV for 11 days or more.
conducted unbiased computer-assisted stereological analysis of whole-mount specimens prepared under standardized unstretched conditions, single-stained with Localization of HSV-TK in GFAP-Positive Enteric cuprolinic blue. This analysis revealed statistically sigGlia and Preferential Loss of These Cells nificant differences of 31% fewer myenteric neurons, from Jejunum and Ileum after GCV and a 27% smaller mean cross-sectional area of reTreatment in Transgenic Mice maining neurons, in the ileum of GCV-treated transgenic To investigate the cause of gut pathology in transgenic mice as compared with controls ( Figures 7A and 7B ). mice receiving GCV, the cellular sites of GFAP and HSVNo qualitative or statistically significant evidence of neu-TK expression were identified in the GI tract by immunoronal loss or atrophy was observed in the colon of GCVhistochemistry. In agreement with previous studies (Jestreated transgenic mice ( Figures 7A and 7B) . Immunosen and Mirsky, 1980; Gershon and Rothman, 1991) , histochemistry revealed no detectable difference in the we observed GFAP-positive enteric glia in an extensive appearance or density of substance P-or tyrosine hynetwork throughout the myenteric and submucosal droxylase-immunoreactive fibers in the ileum (Figures plexuses in whole-mount preparations and cross sec-7F and 7G) of GCV-treated transgenic mice (n ϭ 6) as tions ( Figures 6A and 6G ). In addition, we found many compared with controls (n ϭ 6). Together, these findings GFAP-positive glia within the lamina propria, with proshow that ablation of enteric glia caused a moderate cesses that closely embraced the crypts or extended and patchy, but statistically significant, degeneration of to the distal-most tips of villi ( Figures 6G and 6H) . GFAP neurons intrinsic to the ileal myenteric plexus, without immunoreactivity was not detected in other intestinal obvious structural changes to substance P or sympacell types. In transgenic mice, HSV-TK immunoreactivity thetic innervation. was present in the nuclei and somata of cells with the morphological appearance of enteric glia, and double Selective Decontamination of the Digestive Tract labeling confirmed that HSV-TK was present only in (SDD) Prevents Bacterial Overgrowth but Not GFAP-positive cells (Figures 6B-6D ). After 14 days of Pathological Changes and Inflammation GCV treatment, there was a pronounced, but incomin Jejunum and Ileum of GCV-Treated plete, loss of GFAP-and HSV-TK-positive cells and proTransgenic Mice cesses from the myenteric plexus in the jejunum and Degeneration of enteric neurons can disrupt gut motility and cause bacterial overgrowth, which in extreme cases ileum, and remaining glia had abnormal morphologies (I-L) Confocal microscopy of immunofluorescence for GFAP (green) with propidium iodide as a nuclear counter stain (red). GFAP-immunoreactivity in the ileum is unaltered by GCV (11 days) in a nontransgenic (I) but is ablated from the lamina propria of a transgenic (J) mouse, although small amounts remain in the myenteric plexus (arrow). GFAP loss is associated with thickening of the muscle wall (m), crypt hyperplasia (c), and epithelial degeneration. GFAP-immunoreactivity in the colon shows no obvious difference in GCV-treated nontransgenic (K) and transgenic (L) mice. Scale bar for (I) and (J) ϭ 25 m; for (K) and (L) ϭ 40 m.
showed anaerobic and aerobic colony counts reduced significantly by more than 1 and 6 orders of magnitude, respectively, as compared with GCV-treated transgenic mice not receiving antibiotics ( Figures 8A and 8B ). Functional decontamination of the bowel was further demonstrated by a statistically significant increase (p Ͻ 0.01, t test) of cecal weight relative to body weight in mice with SDD (2.8 Ϯ 0.5%) compared with untreated mice (1.5 Ϯ 0.4%). Aerobic bacterial colony counts were similarly reduced in GCV-treated transgenic mice after 5 days of oral antibiotics (data not shown), indicating effectiveness of SDD during the entire period of development of the intestinal pathology in these mice.
SDD did not reduce the severity of the illness exhibited by GCV-treated transgenic mice as judged by the appearance of the mice, survival time, or severity in the reduction of hemoglobin levels. The small bowel of GCVtreated nontransgenic mice with SDD appeared normal; however, the small bowel of GCV-treated transgenic mice with SDD exhibited severe macro-and microscopic pathology with mucosal degeneration, capillary dilation, erythrostasis, granulocytic inflammatory infiltration, and hemorrhagic necrosis similar to GCV-treated transgenic mice that did not receive antibiotics ( Figures  8C-8G ). Standard microbiological screening and serological tests showed no evidence of contagious pathogens in these mice, such as Clostridium, Salmonella, Yersina, parasites, and various mouse viruses. These findings demonstrate that the pathology induced in transgenic mice by GCV was not merely the result of bacterial overgrowth in the small bowel, but they do not rule out a role for bacteria in the etiology of this pathology.
Myeloperoxidase (MPO) activity deriving from azurophilic granules of polymorphonuclear neutrophils was determined in bowel segments as a specific, quantitative measure of inflammatory response (Miller et al., 1993) . GCV-treated transgenic mice with or without SDD exhibited substantial and statistically significant increases in MPO activity in ileum, but not duodenum or colon, compared with GCV-treated nontransgenic mice with or without SDD ( Figure 8C ). These findings show that the pathological changes of the small bowel in GCVtreated transgenic mice were associated with a pronounced inflammatory infiltrate, which was not prevented by SDD.
Discussion
Enteric glia form a large and widespread network of cells at all levels of the GI tract. Their functions are not may induce inflammatory pathology in the small intestine. We therefore quantitatively assessed bacterial levwell understood. In this study, we found that ablation els in gut segments, and examined the effects of SDD of enteric glia in the jejunum and ileum of adult transachieved with oral antibiotics, on the intestinal patholgenic mice led rapidly to a fulminating enteritis with ogy triggered by GCV in transgenic mice. The ileum, severe inflammation and hemorrhagic necrosis of these but not duodenum or cecum, of GCV-treated transgenic organs. Ablation of enteric glia also caused degenerative mice showed statistically significant 10-to 100-fold inchanges in neural elements of the enteric nervous syscreases in the number of anaerobic and aerobic bactetem, which may have contributed to the development rial colonies per gram tissue, respectively, as compared of the associated pathology. The macro-and histowith untreated or GCV-treated nontransgenic mice (Fig- pathologic appearance of the small intestine was similar ures 8A and 8B). The ileum of GCV-treated transgenic to that in experimental models of inflammatory bowel mice fed diet containing three oral antibiotics (broad disease (IBD) in rodents and in various human conditions. spectrum, antianaerobic, and antifungal) for 14 days
s.c. GCV Treatment Preferentially and Specifically Ablated Transgenic Glia in the Jejunum and Ileum
Most HSV-TK-expressing glial cells throughout the central, peripheral, and enteric nervous systems were not killed in detectable numbers by the regimen of GCV delivery used in this study. The reason for the preferential ablation of HSV-TK-expressing glia in the small intestine is uncertain. After phosphorylation of GCV by transgene-derived HSV-TK, GCV-mediated cell death is thought to result from the formation of toxic intermediates that disrupt DNA replication and kill proliferating cells (Frank et al., 1984; Borrelli et al., 1989) . In agreement with these reports, we found that s.c. GCV treatment killed HSV-TK-expressing CNS astrocytes in vivo only adjacent to a stab injury, a procedure that induces proliferation of local reactive astrocytes. These observations suggest that different rates of cell division amongst HSV-TK-expressing glia may account for variations in their vulnerability to GCV, but other differences cannot be ruled out.
In the small intestine, HSV-TK immunoreactivity was present only in GFAP-positive enteric glia, and not in other cell types. Enteric glia were clearly ablated in the jejunum and ileum by GCV treatment, and there is no evidence to suggest that the lethal metabolites of GCV, which they produced, had any effects on neighboring intestinal cells. In previous reports, GCV treatment of transgenic mice had no toxic effects on non-HSV-TKexpressing cells that were intermingled with cells which expressed HSV-TK and died in the pituitary, thyroid, or stomach (Borrelli et al., 1989; Wallace et al., 1991; Canfield et al., 1996) . In our in vitro experiments, GCV did not kill GFAP-and HSV-TK-negative cells; instead, these cells increased in number while neighboring GFAPin the CNS, disruption of glutamate uptake by astrocytes causes excitotoxic neuronal death (Rothstein et al., positive, HSV-TK-expressing astrocytes died. Together, these findings indicate that lethal metabolites of GCV are 1996). Enteric glia may also influence neural fibers and pronot released by HSV-TK-expressing cells in sufficient quantities to kill neighboring cells, and that GCV specifijections from enteric neurons. The continuous turnover of intestinal mucosa due to epithelial sloughing requires cally ablated enteric glia in the small intestine of our transgenic mice.
constant remodeling of enteric neural connections. This activity is reflected in the constitutive expression by enteric neurons of GAP-43 (Sharkey et al., 1990) . In the Enteric Glia Play a Fundamental Role adult CNS, astrocytes support some types of sprouting in Bowel Function or regenerating axons (Kawaja and Gage, 1991) . GFAPAblation of enteric glial cells in the jejunum and ileum positive enteric glia that envelop axon bundles (Gershon led rapidly to severe inflammation and necrosis. The and Rothman, 1991) may play a similar role, with the persistence of the pathology in mice with SDD showed consequence that loss or dysfunction of enteric glia that this subacute, necrotizing enteritis was not merely could lead to a failure of certain enteric neural projeccaused by bacterial overgrowth resulting from disturbed tions. gut motility due to neuronal degeneration. Thus, func-
The widespread distribution of enteric glia and their tional changes induced by the loss of enteric glia played processes throughout the intestinal mucosa, embracing a primary role in triggering the disease process. To our crypts and extending to the most distal villus tips, sugknowledge, there are no previous reports presenting gests that molecules released from these cells could evidence for, or postulating, a direct link between the influence many cell types. GFAP-positive glial cells in loss or dysfunction of enteric glia and pathological the CNS produce, and are affected by, many growth changes in the bowel. The sequence of events appeared factors and cytokines and participate in inflammatory to involve early breakdown of the epithelium, and microand immune responses (Eddleston and Mucke, 1993) , vascular disturbances. Our observations are also coma capacity that may be shared by GFAP-positive enteric patible with a role for normal gut constituents (food glia (Bar et al., 1997) . CNS astrocytes also induce bloodproteins and bacterial flora) in the inflammatory process.
brain barrier properties in endothelia (Janzer and Raff, The rapid induction of severe intestinal pathology after 1987), and some enteric glia display terminal swellings the ablation of enteric glia demonstrates that these cells resembling the endfeet of CNS astrocytes (Gershon and play a fundamental role in maintaining the integrity of Rothman, 1991), which often anchor astrocytes to blood the bowel. Based on comparison with known functions vessels. In this context, it is interesting that ablation of of related GFAP-expressing glia in other neural systems, enteric glia in this study caused microvascular disturthere are a number of ways in which enteric glia could bances and certain changes resembling ischemic bowel. exert powerful effects on bowel function, either by influencing enteric neurons or through direct interactions Changes Induced by Ablation of Enteric Glia with nonneuronal cell types.
Are Similar to IBD In the CNS, fibrous processes of GFAP-positive astro-
The pathological changes induced in our transgenic cytes surround and contact essentially all types of neumice by ablation of enteric glia, although subacute and rons. Interactions between neurons and glia via these fulminating in nature, bear similarities to IBD in animal processes show considerable plasticity and play impormodels and various human conditions, in particular tant roles in regulating neuronal function (Theodosis and Crohn's disease (Strober and Ehrhardt, 1993; Sharkey MacVicar, 1996) . The denuding of myenteric and submuand Parr, 1996) . The features of IBD are of unknown cosal neurons of glial processes in GCV-treated transetiology in human disease (Goyal and Hirano, 1996) and genic mice is likely to have had a pronounced effect on can be induced to varying degrees in experimental anitheir function. In other neural tissues, glia also provide mals either by treatment with certain chemicals (Sharkey important protective and/or supportive functions for and Parr, 1996) , the targeted deletion of genes for IL-2, neurons. In the Drosophila mutant drop dead, glial cell IL-10, or T cell receptors (Kü hn et al., 1993; Mombaerts degeneration precedes, and is thought to cause, neuet al., 1993; Sadlack et al., 1993) , or the genetically tarronal degeneration (Buchanan and Benzer, 1993) . In the geted disruption of epithelial adhesion (Hermiston and mammalian CNS, GFAP-positive astrocytes buffer neuGordon, 1995) . While these animal models strongly imrons from the accumulation of potentially toxic endogeplicate immune and neural dysfunction in IBD, the casnous molecules and produce neurotrophic growth faccade of cellular events remains uncertain. tors (Eddleston and Mucke, 1993) . Our observations Similarities in the appearance of end-stage pathology demonstrate that loss or dysfunction of enteric glia leads in various bowel conditions suggests that the gut may to substantial degeneration of myenteric neurons, which have limited ways of responding when it is defective. may be due to loss of trophic or neuroprotective funcFor this reason, it is important to identify single events tions. Enteric glia produce glial-derived neurotrophic that are able to trigger complex pathological cascades. factor (GDNF) (Bar et al., 1997) , and embryonic mice In this study, loss or dysfunction of enteric glia played a homozygous for deletion of the genes for GDNF or its primary role in triggering inflammatory bowel pathology, receptor fail to develop enteric neurons (Moore et al., suggesting that these cells may play a role in IBD. The 1996; Pichel et al., 1996; Sanchez et al., 1996) . Enteric enteric nervous system has been implicated in IBD neurons, like CNS neurons, are vulnerable to glutamatethrough partial neural degeneration combined with preservation or increases in proinflammatory peptides such mediated excitotoxicity (Kirchgessner et al., 1997), and
Surgical Procedures
as substance P and sympathetic innervation (Goyal and Surgical procedures were performed under anesthesia with Avertin Hirano, 1996; Sharkey and Parr, 1996; McCafferty et al., (0.015 ml/g) and halothane. Miniosmotic pumps were implanted 1997). Our findings after ablation of enteric glia are subcutaneously as recommended by the manufacturer (Alzet). Stab similar. It is interesting that pronounced degenerative injuries to the forebrain were made with a number 11 scalpel blade changes in the myenteric plexus alone do not precipitate using a rodent stereotaxic apparatus (Kopf, USA).
IBD in experimental animals (Dahl et al., 1987) or in
GCV Administration
patients with Hirschsprung's disease, suggesting that GCV (Roche, UK) was administered continuously at a rate of 100 imbalance of neural regulation, rather than extensive mg/kg/day diluted in sterile physiological saline for 7, 14, or 28 days neuronal degeneration, may be important. As discussed via subcutaneously implanted osmotic minipumps (Alzet, models above, the loss or dysfunction of enteric glia may have 1007D, 2001, 2002, or 2004) . This dose was reported to kill thyroeffects on bowel functions other than, and in addition cytes expressing HSV-TK in transgenic mice (Wallace et al., 1991). to, effects on enteric neurons. We speculate that distur- mens (gut, liver, spleen, mesenteric lymph node) were prepared using either brain heart infusion or blood agar plates. Aerobic and anaerobic bacteriological analysis of the bowel was performed by Experimental Procedures BIBRA International (Surrey, UK). Segments of duodenum, ileum, and cecum in toto were homogenized in Brucella broth, plated onto Gfap-HSV-Tk Fusion Gene Construct blood agar plates, and grown under anaerobic or aerobic conditions. Starting with a 15 kb Gfap-lacZ plasmid, the lacZ sequence was replaced with HSV-Tk sequence ( Figure 1A) . A 1.7 kb XbaI-Bam HI SDD fragment, including the HSV-Tk gene and its polyadenylation signal, SDD was achieved using three antibiotics incorporated into the was inserted into a pBSII-KS vector (Stratagene). The insert was diet (Bioserve, Frenchtown, NJ, USA): a broad spectrum antibiotic reexcised using Sal I and Not I and ligated into the first exon of a (ciprofloxacin, 0.5 mg/g), an antianaerobic agent (metronidazole, Gfap promoter cassette (clone 445) consisting of a modified murine 0.25 mg/g), and an antifungal agent (fluconazole, 0.2 mg/g), which Gfap gene (Johnson et al., 1995) . Integrity of the HSV-Tk insert and retain high concentrations in feces and are used to control bacterial flanking regions was confirmed by single-strand sequencing. The number in the GI tracts of neutropenic patients. Mice consumed Gfap-HSV-Tk fusion gene construct was excised by digestion with 3-6 g per day. SfiI and purified by gel electrophoresis.
MPO Assay Animals
MPO activity from polymorphonuclear neutrophils was assayed Mice were housed in a 12 hr light/dark cycle with controlled tempera- (Miller et al., 1993) in bowel segments (100-250 mg), homogenized, ture and humidity, and allowed free access to food and water. and centrifuged at 20,000 g. Pellets were resuspended, pseudoperTransgenic mice were produced using standard techniques (Hogan oxidase activity negated with hexadecyltrimethlammonium broet al., 1986) . Approximately 2 pl of DNA (500 copies of linearized mide, followed by 3 cycles of sonication, freezing, and thawing. fusion gene construct) were pressure injected into the male pronuSupernatant (10 l) was mixed with 90 l of potassium phosphate cleus of fertilized eggs from superovulated female C57BL/10 ϫ CBA buffer containing O-dianisidine dihydrochloride and H 2O2 and absormice mated with CFLP males (Interfauna, UK). Two-cell stage eggs bence determined at 450 nm. One U of MPO activity was defined were reimplanted into pseudopregnant foster mothers. DNA obas that required to degrade 1 mol of H 2O2 per min at 25ЊC. Values tained by tail biopsy from resulting mice was digested with EcoRI were expressed as MPO units per 100 mg total protein per sample. and screened by Southern blot using a 1.7 kb HSV-TK probe.
Tissue Harvest Western Blot
Mice were killed by terminal barbiturate anesthesia. Dissected tisFrozen cerebral hemispheres were freeze/thawed, homogenized in sues were either frozen in liquid nitrogen and stored at Ϫ70ЊC until lysis buffer (20 mM HEPES [pH 7.5], 0.42 M NaCl, 1.5 mM MgCl2 PCR or sectioning, or fixed in 4% paraformaldehyde and processed 0.2 mM EDTA, 0.5 mM PMSF, 0.25 mM DTT, 50 mM NaF, 1 mM for hematoxylin and eosin (H and E)-stained paraffin sections. Some sodium orthovanadate, and 20% glycerol [w/v]) , and centrifuged at mice were fixed by transcardiac perfusion and frozen sections pre-10,000 g. Supernatant proteins were separated on SDS PAGE and pared. transferred to nitrocellulose membrane. Nonspecific binding sites were blocked with 5% milk powder, followed by incubation in 1:250
RT-PCR rabbit anti-HSV-TK (P. Collins), 1:250 biotinylated anti-rabbit IgG Total RNA was extracted from frozen tissues and reverse tran-(Dako), streptavidin-biotin-horseradish peroxidase complex (ABC; scribed. PCR primers were: Gfap (accession number K01347, forVector), and diaminobenzidine (0.5 mg/ml).
ward GTT GTG AAG GTC TAT TCC TGG C; reverse TCC CTT AGC TTG GAG AGC AA); HSV-Tk (forward GGT CCC GGA TCC GGT GGT GG; reverse CGA GGC GGT GTT GTG TGG TGT); ribosomal protein In Vitro Experiments S29 (Rps29, accession number L31609, forward CTG ATC CGC AAA Primary astrocyte cultures were prepared from brains of individual TAC GGG; reverse GCA TGA TCG GTT CCA CTT G). Primers were neonatal (Ͻ48-hr-old) littermate pups (McCarthy and de Vellis, 1980) . used at 100 ng/reaction. Hot-lid PCR amplification of cDNA was Each culture was genotyped by Southern blot of corresponding liver carried out in PCR buffer containing 0.5 mM dNTPs and 0.6 U Ampli-DNA. Astrocyte vulnerability to GCV was assessed using the MTT Taq DNA polymerase on PTC-225 thermal cyclers (Tetrad). PCR (3-[4,5-Dimethylthylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) asproducts were separated on agarose gel and stained with ethidium say (Hansen et al., 1989) . Sister cultures were grown in triplicate in bromide. the presence or absence of 2 M GCV for up to 7 days. For the assay, medium was replaced by MTT solution (0.5 mg/ml in PBS) for 3 hr; cells were lysed with SDS, and OD measured at 570 nm. For
Immunohistochemistry and Histology Pieces of GI tract tissue, or 40 m thick frozen forebrain sections immunohistochemistry, cultures were fixed in 4% paraformaldehyde and stained as described below for tissue sections.
were stained free-floating in primary antibody overnight, biotinylated
